Edition:
United States

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

3.14USD
4:00pm EDT
Change (% chg)

$0.07 (+2.28%)
Prev Close
$3.07
Open
$3.05
Day's High
$3.48
Day's Low
$3.05
Volume
205,467
Avg. Vol
139,152
52-wk High
$4.51
52-wk Low
$2.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.058
Mar '18 0.00 -0.056
FY 2017 Dec '17 0.00 -0.059
Sep '17 0.00 -0.049
Jun '17 0.00 -0.046
Mar '17 0.00 -0.060
FY 2016 Dec '16 0.00 -0.050
Sep '16 0.00 -0.048
Jun '16 0.00 -0.055
Mar '16 0.00 -0.065
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 5 0.46 2.28 0.00 0.00
Year Ending Dec-18 5 0.46 2.28 0.00 8.05
Year Ending Dec-19 5 30.06 55.00 12.70 46.76
Earnings (per share)
Quarter Ending Sep-18 5 -0.08 -0.06 -0.11 -0.06
Quarter Ending Dec-18 5 -0.10 -0.06 -0.15 -0.06
Year Ending Dec-18 5 -0.29 -0.24 -0.38 -0.25
Year Ending Dec-19 5 -0.15 -0.07 -0.35 0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 107.68 32.65
P/E High - Last 5 Yrs. -- 279.69 47.28
P/E Low - Last 5 Yrs. -- 98.16 24.79
Beta 1.47 0.62 0.87
Price to Sales (TTM) -- 108.66 6.44
Price to Book (MRQ) 4.43 12.37 3.90
Price to Tangible Book (MRQ) 4.43 18.63 5.95
Price to Cash Flow (TTM) -- 61.73 23.45
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.70
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.63 -5.68
Payout Ratio(TTM) -- 5.94 46.50

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 176.86 8.40
Sales (TTM) vs TTM 1 Yr. Ago -- 93.42 6.69
Sales - 5 Yr. Growth Rate -- 24.48 7.57
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.74 282.99 25.61
EPS (TTM) vs TTM 1 Yr. Ago -8.74 -- --
EPS - 5 Yr. Growth Rate -- 23.63 7.61
Capital Spending - 5 Yr. Growth Rate -- 38.58 8.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.62 2.20
Current Ratio (MRQ) 22.42 5.44 2.97
LT Debt to Equity (MRQ) 0.00 15.00 11.19
Total Debt to Equity (MRQ) 0.00 18.46 14.01
Interest Coverage (TTM) -91.43 -201.28 35.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.05 54.65
Gross Margin - 5 Yr. Avg. -- 52.69 53.29
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -175.26 15.94
Operating Margin (TTM) -- -602.86 3.76
Operating Margin - 5 Yr. Avg. -- -188.80 11.06
Pre-Tax Margin (TTM) -- -599.74 4.08
Pre-Tax Margin - 5 Yr. Avg. -- -191.11 11.25
Net Profit Margin (TTM) -- -594.93 0.80
Net Profit Margin - 5 Yr. Avg. -- -188.77 7.58
Effective Tax Rate (TTM) -- 11.62 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.25 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,194,301 714,438,801
Net Income/Employee (TTM) -1,010,971 -5,791,431 82,488,037
Receivable Turnover (TTM) -- 5.37 5.03
Inventory Turnover (TTM) -- 2.07 3.60
Asset Turnover (TTM) 0.00 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -38.51 0.82 9.74
Return on Assets - 5 Yr. Avg. -37.98 2.59 10.91
Return on Investment (TTM) -40.31 1.61 12.72
Return on Investment - 5 Yr. Avg. -41.02 2.07 14.03
Return on Equity (TTM) -40.43 0.32 14.84
Return on Equity - 5 Yr. Avg. -42.36 -2.31 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.60 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catalyst Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.92%
# of Holders: 117
Total Shares Held: 53,273,051
3 Mo. Net Change: -2,028,558
# New Positions: 16
# Closed Positions: 19
# Increased Positions: 72
# Reduced Positions: 45
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.